标题
Schizophrenia and depression, two poles of endocannabinoid system deregulation
作者
关键词
-
出版物
Translational Psychiatry
Volume 7, Issue 12, Pages -
出版商
Springer Nature
发表日期
2017-12-15
DOI
10.1038/s41398-017-0029-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Increased PKC activity and altered GSK3β/NMDAR function drive behavior cycling in HINT1-deficient mice: bipolarity or opposing forces
- (2017) Javier Garzón-Niño et al. Scientific Reports
- A quantitative review of the postmortem evidence for decreased cortical N-methyl-d-aspartate receptor expression levels in schizophrenia: How can we link molecular abnormalities to mismatch negativity deficits?
- (2016) Vibeke S. Catts et al. BIOLOGICAL PSYCHOLOGY
- Role of calcium, glutamate and NMDA in major depression and therapeutic application
- (2016) Lorenz Deutschenbaur et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction
- (2016) María Rodríguez-Muñoz et al. Oncotarget
- The σ1 Receptor Engages the Redox-Regulated HINT1 Protein to Bring Opioid Analgesia Under NMDA Receptor Negative Control
- (2015) María Rodríguez-Muñoz et al. ANTIOXIDANTS & REDOX SIGNALING
- Glutamate and dopamine in schizophrenia: An update for the 21st century
- (2015) Oliver Howes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Ketamine and other potential glutamate antidepressants
- (2015) Arpan Dutta et al. PSYCHIATRY RESEARCH
- Region-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia
- (2014) Ghanshyam N Pandey et al. BIPOLAR DISORDERS
- Targeting of NMDA Receptors in the Treatment of Major Depression
- (2014) Yong-Hui Dang et al. CURRENT PHARMACEUTICAL DESIGN
- The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases
- (2014) Pilar Sánchez-Blázquez et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: Effect of antidepressant treatment
- (2014) Carolina Muguruza et al. NEUROPHARMACOLOGY
- The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia
- (2014) Pilar Sánchez-Blázquez et al. Frontiers in Pharmacology
- Cannabinoid Receptors Couple to NMDA Receptors to Reduce the Production of NO and the Mobilization of Zinc Induced by Glutamate
- (2013) Pilar Sánchez-Blázquez et al. ANTIOXIDANTS & REDOX SIGNALING
- The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain
- (2013) Pilar Sánchez-Blázquez et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A review of ketamine in affective disorders: Current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action
- (2013) Marie Naughton et al. JOURNAL OF AFFECTIVE DISORDERS
- Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
- (2013) E M P Poels et al. MOLECULAR PSYCHIATRY
- Subanesthetic Doses of Ketamine Transiently Decrease Serotonin Transporter Activity: A PET Study in Conscious Monkeys
- (2013) Shigeyuki Yamamoto et al. NEUROPSYCHOPHARMACOLOGY
- Cannabis use and brain structural alterations of the cingulate cortex in early psychosis
- (2013) Charlotte Rapp et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Activation-dependent plasticity of polarized GPCR distribution on the neuronal surface
- (2013) Anne C. Simon et al. Journal of Molecular Cell Biology
- HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity
- (2013) Ana Vicente-Sánchez et al. Molecular Brain
- Mu opioid receptor availability in people with psychiatric disorders who died by suicide: a case control study
- (2012) Elizabeth Scarr et al. BMC Psychiatry
- Targeting the Glutamatergic System to Treat Major Depressive Disorder
- (2012) Daniel C. Mathews et al. DRUGS
- Brain RGS4 and RGS10 protein expression in schizophrenia and depression. Effect of drug treatment
- (2012) G. Rivero et al. PSYCHOPHARMACOLOGY
- Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients
- (2012) D Martins-de-Souza et al. Translational Psychiatry
- The role of serotonin receptors in the action of atypical antipsychotic drugs
- (2011) HY Meltzer et al. CURRENT OPINION IN PHARMACOLOGY
- Differential expression of HINT1 in schizophrenia brain tissue
- (2011) Jeeva Varadarajulu et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- The Mu-Opioid Receptor and the NMDA Receptor Associate in PAG Neurons: Implications in Pain Control
- (2011) María Rodríguez-Muñoz et al. NEUROPSYCHOPHARMACOLOGY
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia
- (2011) Beng-Choon Ho et al. SCHIZOPHRENIA RESEARCH
- Role of Serotonin in Central Dopamine Dysfunction
- (2010) Giuseppe Di Giovanni et al. CNS Neuroscience & Therapeutics
- The endocannabinoid system and psychiatric disorders
- (2010) Daniela Parolaro et al. EXPERIMENTAL NEUROLOGY
- Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder
- (2010) Stephen M Eggan et al. NEUROPSYCHOPHARMACOLOGY
- Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants
- (2010) Boris B. Gorzalka et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats
- (2009) Christian G. Reich et al. BEHAVIOURAL BRAIN RESEARCH
- Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls
- (2009) Richard C. Shelton et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Reduced expression of glutamate receptors and phosphorylation of CREB are responsible forin vivoÎ9-THC exposure-impaired hippocampal synaptic plasticity
- (2009) Ni Fan et al. JOURNAL OF NEUROCHEMISTRY
- Signaling Pathways from Cannabinoid Receptor-1 Activation to Inhibition of N-Methyl-D-Aspartic Acid Mediated Calcium Influx and Neurotoxicity in Dorsal Root Ganglion Neurons
- (2009) Q. Liu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- CNR1 Gene is Associated with High Neuroticism and Low Agreeableness and Interacts with Recent Negative Life Events to Predict Current Depressive Symptoms
- (2009) Gabriella Juhasz et al. NEUROPSYCHOPHARMACOLOGY
- Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress
- (2009) Matthew N. Hill et al. PSYCHONEUROENDOCRINOLOGY
- Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
- (2009) Leyre Urigüen et al. PSYCHOPHARMACOLOGY
- The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants
- (2009) Matthew N. Hill et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
- (2008) Stephen M. Eggan et al. ARCHIVES OF GENERAL PSYCHIATRY
- Developmental Regulation of the NMDA Receptor Subunits, NR3A and NR1, in Human Prefrontal Cortex
- (2008) Maile A. Henson et al. CEREBRAL CORTEX
- Cannabinoid receptor 1 (CNR1) gene: Impact on antidepressant treatment response and emotion processing in Major Depression
- (2008) Katharina Domschke et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Direct Interaction Enables Cross-talk between Ionotropic and Group I Metabotropic Glutamate Receptors
- (2008) Julie Perroy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment
- (2008) Matthew N. Hill et al. JOURNAL OF NEUROCHEMISTRY
- Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A
- (2008) R.C. Shelton et al. NEUROSCIENCE
- Serum Endocannabinoid Content is Altered in Females with Depressive Disorders: A Preliminary Report
- (2008) M. Hill et al. PHARMACOPSYCHIATRY
- Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression
- (2008) Anteneh M. Feyissa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now